UTI (Universal Technical Institute, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by UTI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | ROBERT THOMAS DEVINCENZI | Director | Buy | — | — |
| 2026-08-12 | ROBERT THOMAS DEVINCENZI | Director | Buy | — | — |
| 2026-06-24 | Kevin Prehn | Concorde Division President | Sell | — | — |
| 2026-06-10 | Christopher S Shackelton | Director | Sell | — | — |
| 2026-06-08 | Christine Kline | Senior Vice President and CAO | Sell | — | — |
| 2026-06-08 | WILLIAM J JR LENNOX | Director | G | — | — |
| 2026-05-27 | Tracy Kay Lorenz | SVP and UTI Division President | MIXED | — | — |
| 2026-05-13 | LINDA J SRERE | Director | Sell | — | — |
| 2026-03-18 | George W. Brochick | Director | Sell | — | — |
| 2026-03-09 | Shannon Lei Okinaka | Director | Sell | — | — |
| 2026-03-06 | KENNETH R TRAMMELL | Director | A | — | — |
| 2026-03-06 | Michael A. Slubowski | Director | A | — | — |
| 2026-03-06 | LINDA J SRERE | Director | A | — | — |
| 2026-03-06 | ROBERT THOMAS DEVINCENZI | Director | A | — | — |
| 2026-03-06 | Todd A Hitchcock | EVP/COO | Sell | — | — |
| 2026-03-06 | WILLIAM J JR LENNOX | Director | A | — | — |
| 2026-03-06 | Loretta Lydia Sanchez | Director | A | — | — |
| 2026-03-06 | Shannon Lei Okinaka | Director | A | — | — |
| 2026-03-06 | George W. Brochick | Director | A | — | — |
| 2026-03-06 | Sherrell Smith | EVP, Chief Academic Officer | Sell | — | — |
| 2026-03-04 | Sherrell Smith | EVP, Chief Academic Officer | MIXED | — | — |
| 2026-03-02 | Jerome Alan Grant | Chief Executive Officer | Sell | — | — |
| 2026-02-17 | Carolyn Ann Frank | SVP/Chief HR Officer | Sell | — | — |
| 2026-01-21 | Carolyn Ann Frank | SVP/Chief HR Officer | F | — | — |
| 2025-12-19 | Tracy Kay Lorenz | UTI Division President | F | — | — |
| 2025-12-19 | Sherrell Smith | EVP, Chief Academic Officer | F | — | — |
| 2025-12-19 | Todd A Hitchcock | EVP/COO | F | — | — |
| 2025-12-19 | Kevin Prehn | Concorde Division President | F | — | — |
| 2025-12-19 | Bruce Schuman | Chief Financial Officer | F | — | — |
| 2025-12-19 | Carolyn Ann Frank | SVP/Chief HR Officer | F | — | — |
| 2025-12-19 | Christine Kline | Senior Vice President and CAO | F | — | — |
| 2025-12-19 | Jerome Alan Grant | Chief Executive Officer | F | — | — |
| 2025-12-19 | Adrienne Dawn DeTray | SVP and CIO | F | — | — |
| 2025-12-19 | Christopher E. Kevane | EVP and Chief Legal Officer | F | — | — |
| 2025-12-12 | Bruce Schuman | Chief Financial Officer | A | — | — |
| 2025-12-12 | Tracy Kay Lorenz | UTI Division President | MIXED | — | — |
| 2025-12-12 | Jerome Alan Grant | Chief Executive Officer | MIXED | — | — |
| 2025-12-12 | Carolyn Ann Frank | SVP/Chief HR Officer | A | — | — |
| 2025-12-12 | Kevin Prehn | Concorde Division President | MIXED | — | — |
| 2025-12-12 | Sherrell Smith | EVP, Chief Academic Officer | MIXED | — | — |
| 2025-12-12 | Christine Kline | Senior Vice President and CAO | MIXED | — | — |
| 2025-12-12 | Christopher E. Kevane | EVP and Chief Legal Officer | MIXED | — | — |
| 2025-12-12 | Adrienne Dawn DeTray | SVP and CIO | A | — | — |
| 2025-12-12 | Todd A Hitchcock | EVP/COO | MIXED | — | — |
| 2025-12-10 | Todd A Hitchcock | EVP/COO | A | — | — |
| 2025-12-10 | Christine Kline | Senior Vice President and CAO | A | — | — |
| 2025-12-10 | Christopher E. Kevane | EVP and Chief Legal Officer | A | — | — |
| 2025-12-10 | Sherrell Smith | EVP, Chief Academic Officer | A | — | — |
| 2025-12-10 | Jerome Alan Grant | Chief Executive Officer | A | — | — |
| 2025-12-05 | Christopher S Shackelton | Director | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 2,887,697 | — |
| — | 10%+ Owner | 2,873,882 | — |
| — | Director | 2,716,267 | — |
| — | Director | 2,616,308 | — |
| — | Director | 971,440 | — |
| — | Director | 588,291 | — |
| — | Director | 478,361 | — |
| — | Chief Executive Officer | 430,215 | — |
| — | President and CFO | 328,614 | — |
| — | SVP Chief Information Officer | 265,517 | — |
| — | Director | 222,817 | — |
| — | EVP, Chief Academic Officer | 170,594 | — |
| — | Director | 149,330 | — |
| — | EVP, Gen Counsel & Corp Dev | 146,395 | — |
| — | Director | 136,083 | — |
| — | EVP & CFO | 131,820 | — |
| — | Director | 127,564 | — |
| — | SVP Marketing | 122,740 | — |
| — | Director | 119,723 | — |
| — | Director | 118,568 | — |
| — | EVP and Chief Legal Officer | 107,175 | — |
| — | EVP/COO | 104,084 | — |
| — | Sr. VP, Custom Training Group | 98,160 | — |
| — | EVP and CFO | 94,615 | — |
| — | Director | 89,749 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the UTI quote page; the site-wide leaderboard is on the insider transactions hub.